Risk of peptic ulcer hospitalizations in users of NSAIDs with gastroprotective cotherapy versus coxibs. Ray WA, Chung CP, Stein CM, Smalley WE, Hall K, Arbogast PG, Griffin MR (2007) Gastroenterology 133: 790-8 Underutilization of gastroprotective measures in patients receiving nonsteroidal antiinflammatory drugs. Smalley W, Stein CM, Arbogast PG, Eisen G, Ray WA, Griffin M (2002) Arthritis Rheum 46: 2195-200 Clinical trial: gastric acid suppression in Hispanic adults with symptomatic gastro-oesophageal reflux disease - comparator study of esomeprazole, lansoprazole and pantoprazole. Morgan D, Pandolfino J, Katz PO, Goldstein JL, Barker PN, Illueca M (2010) Aliment Pharmacol Ther 32: 200-8 Different contributions of cytochrome P450 2C19 and 3A4 in the oxidation of omeprazole by human liver microsomes: effects of contents of these two forms in individual human samples. Yamazaki H, Inoue K, Shaw PM, Checovich WJ, Guengerich FP, Shimada T (1997) J Pharmacol Exp Ther 283: 434-42 Gastroesophageal reflux disease as an etiology of sleep disturbance in subjects with insomnia and minimal reflux symptoms: a pilot study of prevalence and response to therapy. Shaheen NJ, Madanick RD, Alattar M, Morgan DR, Davis PH, Galanko JA, Spacek MB, Vaughn BV (2008) Dig Dis Sci 53: 1493-9 Misoprostol, an anti-ulcer agent and PGE2 receptor agonist, protects against cerebral ischemia. Li J, Liang X, Wang Q, Breyer RM, McCullough L, Andreasson K (2008) Neurosci Lett 438: 210-5
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.